ELAN vs. ICLR: Elanco Animal Health vs. ICON Stock Comparison

November 11, 2026

How do Elanco Animal Health (ELAN) and ICON (ICLR) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Elanco Animal Health (ELAN) and ICON (ICLR) both fall under the Pharmaceuticals, Biotechnology & Life Sciences industry group, but ELAN is classified in Pharmaceuticals while ICLR is classified in Life Sciences Tools & Services.

Company profile comparison for Elanco Animal Health (ELAN) and ICON (ICLR)
Profile Item	ELAN	ICLR
Name	Elanco Animal Health Incorporated	ICON plc
Country/Region	United States	Ireland
GICS Sector	Health Care	Health Care
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences	Pharmaceuticals, Biotechnology & Life Sciences
GICS Industry	Pharmaceuticals	Life Sciences Tools & Services
GICS Sub-Industry	Pharmaceuticals	Life Sciences Tools & Services
Market Capitalization	12.86 billion USD	15.34 billion USD
Currency	USD	USD
Exchange	NYSE	Nasdaq
Listing Date	September 20, 2018	May 15, 1998
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

ELAN

ICLR

GSPC

Elanco Animal Health (ELAN) vs. ICON (ICLR), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for Elanco Animal Health (ELAN) and ICON (ICLR). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for Elanco Animal Health (ELAN) and ICON (ICLR). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Elanco Animal Health (ELAN) and ICON (ICLR)
Metric	ELAN	ICLR
Total Return (1Y)	24.03%	30.55%
Total Return (3Y, Annualized)	37.47%	-6.05%
Total Return (5Y, Annualized)	-4.24%	-5.40%

Risk Profile

Drawdown History

ELAN

ICLR

GSPC

Elanco Animal Health (ELAN) vs. ICON (ICLR), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for Elanco Animal Health (ELAN) and ICON (ICLR). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Elanco Animal Health (ELAN) and ICON (ICLR)
Metric	ELAN	ICLR
Volatility (1Y, Annualized)	43.57%	68.62%
Beta (5Y)	1.65	1.17
Max Drawdown (5Y)	-75.59%	-76.87%
Avg. Volume (3M)	5.65M	943.50K

Risk-Adjusted Performance

Risk-Return Positioning

ELAN and ICLR are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Elanco Animal Health (ELAN) and ICON (ICLR)
Metric	ELAN	ICLR
Sharpe Ratio (1Y)	0.45	0.38
Sortino Ratio (1Y)	0.66	0.52

Profitability

ROE (TTM)

Capital efficiency shows on one side only: ICON (ICLR) earns 4.70% on shareholders’ equity, ranked against its industry; Elanco Animal Health (ELAN) has no ROE this period.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

Max: 109.18%
Q3: 6.23%
Median: -26.66%
Q1: -64.05%
Min: -167.77%
ELAN: --

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

4.70%

Max: 109.18%
Q3: 6.23%
ICLR: 4.70%
Median: -26.66%
Q1: -64.05%
Min: -167.77%

Elanco Animal Health (ELAN) vs. ICON (ICLR): ELAN does not report ROE, so it has no value marker; ICLR is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Net Margin (TTM)

Elanco Animal Health (ELAN) reports a negative net margin of -2.86%, usually indicating a net loss over the period. Meanwhile ICON (ICLR) reports 5.26%, ranking against industry peers normally.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

-2.86%

Max: 18.05%
Q3: 4.78%
Median: 0.00%
ELAN: -2.86%
Q1: -4.14%
Min: -17.05%

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.26%

Max: 18.05%
ICLR: 5.26%
Q3: 4.78%
Median: 0.00%
Q1: -4.14%
Min: -17.05%

Elanco Animal Health (ELAN) vs. ICON (ICLR): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Both Elanco Animal Health (ELAN) at 6.64% and ICON (ICLR) at 10.73% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.64%

Max: 83.12%
Q3: 14.77%
ELAN: 6.64%
Median: 0.00%
Q1: -78.82%
Min: -207.40%

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

10.73%

Max: 83.12%
Q3: 14.77%
ICLR: 10.73%
Median: 0.00%
Q1: -78.82%
Min: -207.40%

Elanco Animal Health (ELAN) vs. ICON (ICLR): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for Elanco Animal Health (ELAN) and ICON (ICLR)
Metric	ELAN	ICLR
ROE (TTM)	--	4.70%
ROA (TTM)	--	0.85%
Net Margin (TTM)	-2.86%	5.26%
Operating Margin (TTM)	6.64%	10.73%
Gross Margin (TTM)	56.18%	23.44%

Growth

Revenue Growth

Both Elanco Animal Health (ELAN) at 6.22% and ICON (ICLR) at 0.76% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Elanco Animal Health (ELAN) vs. ICON (ICLR): A comparison of their Revenue Growth across different time periods.

EPS Growth

Both Elanco Animal Health (ELAN) at -169.12% and ICON (ICLR) at -71.56% post bottom-quartile EPS growth versus peers, pointing to weaker earnings momentum than typical rivals.

Elanco Animal Health (ELAN) vs. ICON (ICLR): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Elanco Animal Health (ELAN) and ICON (ICLR)
Metric	ELAN	ICLR
Revenue Growth (YoY)	6.22%	0.76%
Revenue Growth (3Y CAGR)	2.25%	2.15%
EPS Growth (YoY)	-169.12%	-71.56%
EPS Growth (3Y CAGR)	--	-23.82%

Financial Strength

Current Ratio (MRQ)

Short-term liquidity can only be read on one side of this pairing: ICON (ICLR) shows current ratio of 1.32 against its industry benchmark, while Elanco Animal Health (ELAN) has no reading this period.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

Max: 25.13
Q3: 12.13
Median: 5.52
Q1: 2.47
Min: 0.10
ELAN: --

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.32

Max: 25.13
Q3: 12.13
Median: 5.52
Q1: 2.47
ICLR: 1.32
Min: 0.10

Elanco Animal Health (ELAN) vs. ICON (ICLR): ELAN does not report current ratio, so it has no value marker; ICLR is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Debt / Equity (MRQ)

Both Elanco Animal Health (ELAN) at 0.64 and ICON (ICLR) at 0.38 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.64

Max: 1.42
Q3: 0.65
ELAN: 0.64
Median: 0.15
Q1: 0.02
Min: 0.00

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.38

Max: 1.42
Q3: 0.65
ICLR: 0.38
Median: 0.15
Q1: 0.02
Min: 0.00

Elanco Animal Health (ELAN) vs. ICON (ICLR): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Elanco Animal Health (ELAN) and ICON (ICLR)
Metric	ELAN	ICLR
Current Ratio (MRQ)	--	1.32
Debt / Equity (MRQ)	0.64	0.38
Net Debt / EBITDA	3.49	5.55

Dividends

Dividend Yield (TTM)

Neither Elanco Animal Health (ELAN) nor ICON (ICLR) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ELAN: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ICLR: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Elanco Animal Health (ELAN) vs. ICON (ICLR): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

Neither Elanco Animal Health (ELAN) nor ICON (ICLR) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ELAN: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ICLR: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Elanco Animal Health (ELAN) vs. ICON (ICLR): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for Elanco Animal Health (ELAN) and ICON (ICLR)
Metric	ELAN	ICLR
Dividend Yield (TTM)	0.00%	0.00%
Dividend Payout Ratio (TTM)	0.00%	0.00%

Valuation

P/E Ratio (TTM)

An earnings multiple is available for just one side: ICON (ICLR) trades at 81.90 times trailing earnings, ranked against its peers, while Elanco Animal Health (ELAN) has no P/E ratio this period.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

Max: 85.34
Q3: 43.46
Median: 26.69
Q1: 13.30
Min: 0.07
ELAN: --

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

81.90

Max: 85.34
ICLR: 81.90
Q3: 43.46
Median: 26.69
Q1: 13.30
Min: 0.07

Elanco Animal Health (ELAN) vs. ICON (ICLR): ELAN does not report P/E ratio, so it has no value marker; ICLR is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

P/S Ratio (TTM)

Both Elanco Animal Health (ELAN) at 2.50 and ICON (ICLR) at 1.86 fetch a relatively low price per dollar of sales, landing in the cheaper P/S ratio quartile of their industries.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.50

Max: 58.18
Q3: 25.77
Median: 7.30
Q1: 3.01
ELAN: 2.50
Min: 0.01

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.86

Max: 58.18
Q3: 25.77
Median: 7.30
Q1: 3.01
ICLR: 1.86
Min: 0.01

Elanco Animal Health (ELAN) vs. ICON (ICLR): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

ICON (ICLR) at 1.68 sits in the lower P/B ratio quartile against book while Elanco Animal Health (ELAN) at 1.95 is valued near its industry’s middle — ICLR is cheaper on assets, though weigh it against ROE and asset quality.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.95

Max: 13.53
Q3: 6.54
Median: 3.25
ELAN: 1.95
Q1: 1.69
Min: -5.59

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.68

Max: 13.53
Q3: 6.54
Median: 3.25
Q1: 1.69
ICLR: 1.68
Min: -5.59

Elanco Animal Health (ELAN) vs. ICON (ICLR): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for Elanco Animal Health (ELAN) and ICON (ICLR)
Metric	ELAN	ICLR
P/E Ratio (TTM)	--	81.90
P/S Ratio (TTM)	2.50	1.86
P/B Ratio (MRQ)	1.95	1.68
Free Cash Flow Yield (TTM)	--	3.51%